National Microbiology Framework - Lot 4: Clinical Laboratory Diagnostic Testing Services

CPV: Laboratory services

Bids received

57 bids received · 50 suppliers appointed

Procedure method

Open procedure

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Framework agreement

Who may use this agreement

Not stated in the notice; call-off rights may be limited to the establishing authority

Competition type

Competitive procedure

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

18 Apr 2021, 22:54 BST

Last source update

18 Apr 2021, 22:54 BST

FTS notice number

2021/S 000-008144

Classification (CPV)

Laboratory services

Delivery area

UK

Official registry OCID

ocds-h6vhtk-02a741 Find a Tender

Publisher note: The framework is intended to be accessed by: Public Health England; Department of Health and Social Care; Public Health Wales; Public Health Scotland; Department for Health for Northern Ireland; Health and Social Care Northern Ireland; NHS Authorities, NHS Trusts, NHS Foundation Trusts, Special Health Authorities, NHS Scotland Health Boards, NHS Wales Health Boards, NHS Northern Ireland Health Boards, Special NHS Boards and any other NHS entity; Local Authorities; any other bodies governed by public law (as defined in regulation 2 of the Public Contracts Regulations 2015 (SI 2015/102) (as amended); and academic or charitable institutions (including any such institutions that are not Contracting Authorities). Examples of such bodies can be found at the following links (as of date of publication): https://www.gov.uk/government/organisations/charity-commission https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx The framework value is an approximate estimate only. The actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements. PHE works with DHSC and the NHS in its role as a national and international emergency responder to current and emerging threats to public health. As demonstrated by the COVID-19 pandemic, the exact nature, timing and escalation of such threats (and the corresponding required responses) can be difficult to foresee, making any exercise in future value estimation unpredictable. The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier’s range under the Framework Agreement if one or more of the following circumstances apply: • Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice); • Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice); • Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or • Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier’s range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).

1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

• Accora LimitedFramework contractor Cambridge, UK
• Acculabs Diagnostics LtdFramework contractor Teesside, UK
• Alphabiolaboratories Analytical Ltd (T/A AlphaBiolabs)Framework contractor Warrington, UK
• BGI Genomics UK CO LTDFramework contractor London, UK
• Berkshire and Surrey Pathology Services (Frimley Health NHS Foundation Trust),Framework contractor Camberley, UK
• BioClavis LimitedFramework contractor Glasgow, UK
• Cambridge Clinical Laboratories LtdFramework contractor Cambridge, UK
• Covance Laboratories LimitedFramework contractor Harrogate, UK
• Covid Testing Network LimitedFramework contractor Abingdon, UK
• Crown Laboratories Limited,Framework contractor London, UK

No document links were published on the notice.